Baseline BMI and BMI variation during first line pembrolizumab in NSCLC patients with a PD-L1 expression >= 50%: a multicenter study with external validation

A Cortellini; B Ricciuti; M Tiseo; E Bria; GL Banna; Joachim Aerts; F Barbieri; R Giusti; DL Cortinovis; MR Migliorino; A Catino; F Passiglia; M Torniai; A Morabito; C Genova; F Mazzoni; V Di Noia; D Signorelli; A Gelibter; MA Occhipinti; F Rastelli; R Chiari; D De Rocco; A Inno; M De Tursi; P Di Marino; G Mansueto; F Zoratto; F Grossi; M Filetti; P Pizzutilo; M Russano; F Citarella; Luca Cantini; G Targato; O Nigro; MG Ferrara; S Buti; S Scodes; L Landi; G Guaitoli; L Della Gravara; F Tabbo; S Ricciardi; A De Toma; A Friedlaender; F Petrelli; A Addeo; G Porzio; C Ficorella

doi:10.1136/jitc-2020-001403

Baseline BMI and BMI variation during first line pembrolizumab in NSCLC patients with a PD-L1 expression >= 50%: a multicenter study with external validation

A Cortellini
, B Ricciuti
, M Tiseo
, E Bria
, GL Banna
, Joachim Aerts
, F Barbieri
, R Giusti
, DL Cortinovis
, MR Migliorino
, A Catino
, F Passiglia
, M Torniai
, A Morabito
, C Genova
, F Mazzoni
, V Di Noia
, D Signorelli
, A Gelibter
, MA Occhipinti

F Rastelli, R Chiari, D De Rocco, A Inno, M De Tursi, P Di Marino, G Mansueto, F Zoratto, F Grossi, M Filetti, P Pizzutilo, M Russano, F Citarella, Luca Cantini, G Targato, O Nigro, MG Ferrara, S Buti, S Scodes, L Landi, G Guaitoli, L Della Gravara, F Tabbo, S Ricciardi, A De Toma, A Friedlaender, F Petrelli, A Addeo, G Porzio, C Ficorella

Pulmonary Medicine

External organisation

Research output: Contribution to journal › Article › Academic › peer-review

84 Citations (Scopus)

47 Downloads (Pure)

Original language	English
Article number	e001403
Journal	Journal for ImmunoTherapy of Cancer
Volume	8
Issue number	2
DOIs	https://doi.org/10.1136/jitc-2020-001403
Publication status	Published - 2020

Research programs

EMC MM-04-42-02

Access to Document

10.1136/jitc-2020-001403

Repub_132000_O-A.pdfFinal published version, 1.17 MB

http://hdl.handle.net/1765/132000

Cite this

Cortellini, A., Ricciuti, B., Tiseo, M., Bria, E., Banna, GL., Aerts, J., Barbieri, F., Giusti, R., Cortinovis, DL., Migliorino, MR., Catino, A., Passiglia, F., Torniai, M., Morabito, A., Genova, C., Mazzoni, F., Di Noia, V., Signorelli, D., Gelibter, A., ... Ficorella, C. (2020). Baseline BMI and BMI variation during first line pembrolizumab in NSCLC patients with a PD-L1 expression >= 50%: a multicenter study with external validation. Journal for ImmunoTherapy of Cancer, 8(2), Article e001403. https://doi.org/10.1136/jitc-2020-001403

@article{272a2ceba44e40c7a13c9a6cea75df00,

title = "Baseline BMI and BMI variation during first line pembrolizumab in NSCLC patients with a PD-L1 expression >= 50\%: a multicenter study with external validation",

author = "A Cortellini and B Ricciuti and M Tiseo and E Bria and GL Banna and Joachim Aerts and F Barbieri and R Giusti and DL Cortinovis and MR Migliorino and A Catino and F Passiglia and M Torniai and A Morabito and C Genova and F Mazzoni and \{Di Noia\}, V and D Signorelli and A Gelibter and MA Occhipinti and F Rastelli and R Chiari and \{De Rocco\}, D and A Inno and \{De Tursi\}, M and \{Di Marino\}, P and G Mansueto and F Zoratto and F Grossi and M Filetti and P Pizzutilo and M Russano and F Citarella and Luca Cantini and G Targato and O Nigro and MG Ferrara and S Buti and S Scodes and L Landi and G Guaitoli and \{Della Gravara\}, L and F Tabbo and S Ricciardi and \{De Toma\}, A and A Friedlaender and F Petrelli and A Addeo and G Porzio and C Ficorella",

year = "2020",

doi = "10.1136/jitc-2020-001403",

language = "English",

volume = "8",

journal = "Journal for ImmunoTherapy of Cancer",

issn = "2051-1426",

publisher = "BMJ Publishing Group",

number = "2",

}

Cortellini, A, Ricciuti, B, Tiseo, M, Bria, E, Banna, GL, Aerts, J, Barbieri, F, Giusti, R, Cortinovis, DL, Migliorino, MR, Catino, A, Passiglia, F, Torniai, M, Morabito, A, Genova, C, Mazzoni, F, Di Noia, V, Signorelli, D, Gelibter, A, Occhipinti, MA, Rastelli, F, Chiari, R, De Rocco, D, Inno, A, De Tursi, M, Di Marino, P, Mansueto, G, Zoratto, F, Grossi, F, Filetti, M, Pizzutilo, P, Russano, M, Citarella, F, Cantini, L, Targato, G, Nigro, O, Ferrara, MG, Buti, S, Scodes, S, Landi, L, Guaitoli, G, Della Gravara, L, Tabbo, F, Ricciardi, S, De Toma, A, Friedlaender, A, Petrelli, F, Addeo, A, Porzio, G & Ficorella, C 2020, 'Baseline BMI and BMI variation during first line pembrolizumab in NSCLC patients with a PD-L1 expression >= 50%: a multicenter study with external validation', Journal for ImmunoTherapy of Cancer, vol. 8, no. 2, e001403. https://doi.org/10.1136/jitc-2020-001403

TY - JOUR

T1 - Baseline BMI and BMI variation during first line pembrolizumab in NSCLC patients with a PD-L1 expression >= 50%: a multicenter study with external validation

AU - Cortellini, A

AU - Ricciuti, B

AU - Tiseo, M

AU - Bria, E

AU - Banna, GL

AU - Aerts, Joachim

AU - Barbieri, F

AU - Giusti, R

AU - Cortinovis, DL

AU - Migliorino, MR

AU - Catino, A

AU - Passiglia, F

AU - Torniai, M

AU - Morabito, A

AU - Genova, C

AU - Mazzoni, F

AU - Di Noia, V

AU - Signorelli, D

AU - Gelibter, A

AU - Occhipinti, MA

AU - Rastelli, F

AU - Chiari, R

AU - De Rocco, D

AU - Inno, A

AU - De Tursi, M

AU - Di Marino, P

AU - Mansueto, G

AU - Zoratto, F

AU - Grossi, F

AU - Filetti, M

AU - Pizzutilo, P

AU - Russano, M

AU - Citarella, F

AU - Cantini, Luca

AU - Targato, G

AU - Nigro, O

AU - Ferrara, MG

AU - Buti, S

AU - Scodes, S

AU - Landi, L

AU - Guaitoli, G

AU - Della Gravara, L

AU - Tabbo, F

AU - Ricciardi, S

AU - De Toma, A

AU - Friedlaender, A

AU - Petrelli, F

AU - Addeo, A

AU - Porzio, G

AU - Ficorella, C

PY - 2020

Y1 - 2020

U2 - 10.1136/jitc-2020-001403

DO - 10.1136/jitc-2020-001403

M3 - Article

C2 - 33077515

SN - 2051-1426

VL - 8

JO - Journal for ImmunoTherapy of Cancer

JF - Journal for ImmunoTherapy of Cancer

IS - 2

M1 - e001403

ER -